The Department of Health and Social Care (DH) has issued supply notification for various strengths of three H2-antagonists- Cimetidine, Famotidine, and Nizatidine.
Product | Supplier | Anticipated Resupply date | Detail |
Famotidine 20mg tablets | Tilomed Laboratories | Out of stock, resupply mid October 2020 | |
Teva UK | Out of stock, resupply w/c 5th October 2020 | ||
Famotidine 40mg tablets | Tilomed Laboratories | In stock | |
Teva UK | Out of stock, resupply w/c 5th October 2020 | ||
Cimetidine 200mg tablets | Ennogen Pharma | June 2021 | Unlicensed supplies have been sourced |
Medreich | to be confirmed | ||
Cimetidine 400mg tablets | Ennogen Pharma | June 2021 | |
Medreich | to be confirmed | ||
Cimetidine 800mg tablets | Ennogen Pharma | June 2021 | |
Medreich | to be confirmed | ||
Cimetidine 200mg/5ml oral solution | Rosemont Pharmaceuticals | n/a | In stock |
Nizatidine 150mg tablets | Mylan | Out of stock, resupply December 2020 | |
Medreich | to be confirmed | ||
Relonchem | In stock | ||
Nizatidine 300mg tablets | Mylan | Out of stock, resupply December 2020 | |
Medreich | to be confirmed | ||
Relonchem | In stock |
The following specialist importers have confirmed that they can source unlicensed Cimetidine tablets.
- Alium Medical (200mg, 400mg and 800mg)
- Mawdsley’s Unlicensed (400mg)
There is currently no listing on dm+d for the imported product for prescribers to select using their prescribing systems so an EPS prescription for unlicensed Cimetidine (strength) tablets cannot be issued.
If a prescriber wishes to prescribe an unlicensed import, an FP10 paper prescription should be issued as ‘Cimetidine (strength) tablets (Special Order)‘ and endorsed by the pharmacy as a non-Part VIIIB special.